Although the physiological basis of erythermalgia, an autosomal dominant painful neuropathy characterized by redness of the skin and intermittent burning sensation of extremities, is not known, two mutations of Na v 1.7, a sodium channel that produces a tetrodotoxinsensitive, fast-inactivating current that is preferentially expressed in dorsal root ganglia (DRG) and sympathetic ganglia neurons, have recently been identified in patients with primary erythermalgia. Na v 1.7 is preferentially expressed in small-diameter DRG neurons, most of which are nociceptors, and is characterized by slow recovery from inactivation and by slow closed-state inactivation that results in relatively large responses to small, subthreshold depolarizations. Here we show that these mutations in Na v 1.7 produce a hyperpolarizing shift in activation and slow deactivation. We also show that these mutations cause an increase in amplitude of the current produced by Na v 1.7 in response to slow, small depolarizations. These observations provide the first demonstration of altered sodium channel function associated with an inherited painful neuropathy and suggest that these physiological changes, which confer hyperexcitability on peripheral sensory and sympathetic neurons, contribute to symptom production in hereditary erythermalgia.
Introduction
Sensory neurons in dorsal root ganglia (DRG) express multiple voltage-gated sodium channels including Na v 1.7 (Klugbauer et al., 1995; Sangameswaran et al., 1997) , Na v 1.8 (Akopian et al., 1996; Sangameswaran et al., 1996) , and Na v 1.9 (Dib-Hajj et al., 1998; Tate et al., 1998) , which play important roles in regulating their excitability (Matzner and Devor, 1994; Cummins et al., 1998 Cummins et al., , 1999 Renganathan et al., 2001) . Na v 1.7 is selectively expressed in DRG and sympathetic ganglia (Black et al., 1996; Toledo-Aral et al., 1997) and is abundant in small-diameter DRG neurons (Black et al., 1996 (Black et al., , 2004 , including nociceptors (Djouhri et al., 2003a) . Recombinant Na v 1.7 produces a fastinactivating tetrodotoxin-sensitive (TTX-S) current (Klugbauer et al., 1995; Sangameswaran et al., 1997) and displays slow repriming and slow closed-state inactivation that poise it to respond to small, slow depolarizations (Cummins et al., 1998; Herzog et al., 2003) .
It is now well established that dysregulated expression of sodium channel genes, for example Na v 1.3, can produce changes in sodium currents within spinal sensory neurons that contribute to neuropathic pain (Cummins and Waxman, 1997; Black et al., 1999; Hains et al., 2004) . Recently, Na v 1.7 expression in DRG neurons has been shown to increase after carrageenan-induced inflammation of rat hindpaw (Black et al., 2004) . The dynamic regulation of Na v 1.7 suggests that this channel contributes to neuronal hyperexcitability leading to inflammatory pain.
In contrast to dysregulated sodium channel expression, to date there have been no demonstrations of changes in sodium currents attributable to mutations associated with pain. Familial primary erythermalgia is a rare, dominantly inherited painful neuropathy that is manifested as burning pain and redness of the extremities (van Genderen et al., 1993) . Layzer (2001) hypothesized that sensitized C-fibers and the axon reflex underlie these symptoms. A segment of chromosome 2, which is known to contain sodium channel genes, has been linked to primary erythermalgia (Drenth et al., 2001 ). Subsequently, Yang et al. (2004) showed that two independent mutations in SCN9A, which encodes Na v 1.7, are linked to this disorder. The two substitutions produce a change of isoleucine 848 to threonine (I848T) and leucine 858 to histidine (L858H).
We investigated the effect of the I848T and L858H mutations on the biophysical properties of hNa v 1.7. Both mutations cause a significant hyperpolarizing shift in the V 1/2 of activation of the mutant channel, which was accompanied by a larger ramp current. Our data are consistent with a role of Na v 1.7 in DRG neuron hyperexcitability in erythermalgia.
Materials and Methods
Plasmids. The plasmid carrying the human Na v 1.7 cDNA insert was described previously (Klugbauer et al., 1995) . The TTX-S determinant res-idue of Na v 1.7, tyrosine 362, was changed by site-directed mutagenesis to a serine to render the channel resistant to TTX (Na v 1.7 R ) (Herzog et al., 2003) . The I848T and L858H were individually introduced into Na v 1.7 R using the Quick Change XL site-directed mutagenesis kit (Stratagene, La Jolla, CA) with two mutagenic primers that were designed according to the manufacturer recommendations.
Transfections. The hNa v 1.7 channels were cotransfected with the human ␤1 and ␤2 subunits (Lossin et al., 2002) into human embryonic kidney (HEK293) cells using the calcium phosphate precipitation method. HEK293 cells were grown under standard tissue culture conditions (5% CO 2 ; 37°C) in DMEM supplemented with 10% fetal bovine serum. The calcium phosphate-DNA mixture was added to the cell culture medium and left for 3 hr, after which the cells were washed with fresh medium. Sodium currents were recorded 40 -72 hr after transfection.
Whole-cell patch-clamp recordings. Whole-cell patch-clamp recordings were conducted at room temperature (ϳ21°C) using an EPC-10 amplifier and the Pulse program (v 8.5; HEKA Elektronik, Lambrecht/Pfalz, Germany). Fire-polished electrodes (0.8 -1.5 M⍀) were fabricated from 1.7 mm VWR Scientific (West Chester, PA) capillary glass using a Sutter Instruments (Novato, CA) P-97 puller. Average access resistance was 1.4 Ϯ 0.4 M⍀ (mean Ϯ SD; n ϭ 85). Voltage errors were minimized using 80% series resistance compensation; the capacitance artifact was canceled using computer-controlled circuitry of the patch-clamp amplifier. Linear leak subtraction was used for all voltage-clamp recordings. Recordings were always started 3 min after establishing the whole-cell configuration. Membrane currents were filtered at 5 kHz and sampled at 20 kHz. The pipette solution contained the following (in mM): 140 CsF, 1 EGTA, 10 NaCl, and 10 HEPES, pH 7.3. The standard bathing solution was the following (in mM): 140 NaCl, 3 KCl, 1 MgCl 2 , 1 CaCl 2 , and 10 HEPES, pH 7.3. Data were analyzed using Pulsefit (HEKA Elektronik) and Origin (Microcal Software, Northampton, MA) software. Data sets used for statistical analysis were checked for normal distributions using a ShapiroWilks normality test.
Unless otherwise noted, statistical significance was determined ( p Ͻ 0.05) using an unpaired t test. Results are presented as mean Ϯ SEM and error bars in the figures represent SEs.
Results
Wild-type (WT) hNa v 1.7 R and the two mutant derivative channels I848T and L858H were transiently expressed along with h␤-1 and h␤-2 subunits in HEK293 cells. Figure 1 A shows representative whole-cell currents. Although similar peak current densities were recorded from cells expressing WT (318 Ϯ 43 pA/pF; n ϭ 29) and I848T (350 Ϯ 37 pA/pF; n ϭ 27) channels, the current densities recorded from cells expressing L858H channels were significantly smaller (174 Ϯ 30 pA/pF; n ϭ 27). The voltage dependence of activation was examined using a series of depolarizing test pulses from Ϫ100 mV. Mutant channels activated at potentials 10 -15 mV more negative than WT channels ( Fig.  1 B) . The midpoint of activation (estimated by fitting the data with a Bolztman function) was significantly more negative for I848T currents (Ϫ38.4 Ϯ 1.0 mV; n ϭ 27) and L858H currents (Ϫ37.9 Ϯ 0.9 mV; n ϭ 27) than for WT currents (Ϫ24.6 Ϯ 1.1 mV; n ϭ 29). Although the midpoint of activation was almost identical for I848T and L858H channels, the threshold for activation appeared to be ϳ5 mV more negative for L858H channels than for I848T channels. The kinetics of deactivation, which reflects the transition from the open to the closed state, of WT and mutant channels was also examined by eliciting tail currents at a range of potentials after briefly activating the channels (at Ϫ20 mV for 0.5 msec). Altered deactivation of skeletal muscle sodium channels is thought to contribute to the pathophysiology of paramyotonia congenita (Featherstone et al., 1998) . I848T and L858H currents exhibited slower kinetics of deactivation (Fig. 1C) . The time constant of deactivation (measured with single exponential fits) was slower at potentials ranging from Ϫ100 mV to Ϫ40 mV for the mutant channels. Interestingly, the effect on deactivation was much greater with the L858H mutation than with the I848T mutation at all deactivation voltages tested. For example, the deactivation time constants for I848T and L858H channels at Ϫ50 mV were approximately threefold and ϳ10-fold, respectively, larger than that of WT channels.
The fast-inactivation time constant, which provides a measure of the open-to-inactivated transition, was estimated using m 3 h Hodgkin and Huxley type fits to the current data. The time constants for fast inactivation between Ϫ40 and Ϫ20 mV were smaller for the mutant channels than for WT channels (Fig. 2 A) . However, the time constants of the three channels were similar at more depolarized potentials.
In contrast to the dramatic differences in the voltage dependence of activation, the voltage dependence of steady-state fast inactivation was similar for WT, I848T, and L858H (Fig. 2 B) . The midpoint of fast inactivation (measured with 500 msec prepulses) was not significantly different for WT (Ϫ73.6 Ϯ 1.1 mV; n ϭ 20), I848T (Ϫ75.8 Ϯ 1.1 mV; n ϭ 19), and L858H (Ϫ76.1 Ϯ 1.2 mV; n ϭ 17) channels. The steady-state fast-inactivation curve for L858H channels deviated from that of the other channels at negative voltages (e.g., between Ϫ120 and Ϫ80 mV). This Figure 1 . The I848T and L858H mutations of hNa v 1.7 alter activation and deactivation. A, Current traces recorded from representative HEK293 cells expressing either wild-type hNa v 1.7 or mutant channels, I848T or L858H. Cells were held at Ϫ100 mV, and currents were elicited with 50 msec test pulses to potentials ranging from Ϫ80 to 40 mV. B, Normalized peak currentvoltage relationship for wild-type (filled squares; n ϭ 29), I848T (open circles; n ϭ 27), and L858H (open triangles; n ϭ 27) channels. C, Representative tail currents of WT, I848T, and L858H channels. Cells were held at Ϫ100 mV and depolarized to Ϫ20 mV for 0.5 msec, followed by a repolarization to Ϫ50 mV to elicit tail currents. D, Time constants for tail current deactivation at repolarization potentials ranging from Ϫ40 to Ϫ100 mV for wild-type (filled squares; n ϭ 7), I848T (open circles; n ϭ 7), and L858H (open triangles; n ϭ 7) hNa v 1.7 channels. Time constants were obtained with single exponential fits to the deactivation phase of the currents. Error bars represent SE.
is likely attributable to differences in slow inactivation (see below).
Defective slow inactivation of skeletal muscle sodium channels has been proposed to play a role in hyperkalemic periodic paralysis, and therefore, we also examined the voltage dependence of steadystate slow inactivation of hNa v 1.7 currents. Thirty second prepulses, followed by 100 msec recovery pulses to Ϫ120 mV to allow recovery from fast inactivation, preceded the test pulse (to 0 mV for 20 msec) to determine the fraction of current available. Dramatic differences were observed for slow-inactivation properties of WT, I848T, and L858H currents (Fig. 2C) . Surprisingly, the L858H mutation substantially enhanced slow inactivation of hNa v 1.7. This enhancement of slow inactivation is likely to account for the enhanced inactivation of L858H currents observed at negative potentials with the steadystate fast-inactivation protocol (Fig. 2 B) . In contrast, the I848T mutations impaired slow inactivation of hNa v 1.7 channels. At 0 mV, only 67 Ϯ 6% of I848T channels (n ϭ 8) are slow inactivated (determined from the fraction of channels available for activation as measured in Fig. 2C ) compared with 84 Ϯ 4% of WT channels (n ϭ 8) and Ͼ97 Ϯ 2% of L858H channels (n ϭ 7). For both mutants, the percentage of channels that were slow inactivated at 0 mV was significantly different than for WT channels. Therefore, the two mutations identified in the Na v 1.7 channels of patients with primary erythermalgia have differential effects on slow inactivation of hNa v 1.7 channels.
Finally, we examined the currents induced in hNa v 1.7 channels by slow ramp depolarizations. Significantly larger currents were elicited with slow ramp (0.2 mV/ms) depolarizations from Ϫ100 to ϩ20 mV by either I848T or L858H channels compared with WT channels (Fig. 3) . The ramp currents (expressed as a percentage of peak current) were 1.8 Ϯ 0.2% for I848T channels (n ϭ 19), 2.6 Ϯ 0.3% for L858H channels (n ϭ 16), and 0.6 Ϯ 0.1% for WT channels (n ϭ 16). The ramp currents in cells expressing I848T and L858H channels were pronounced between Ϫ70 and Ϫ40 mV (Fig. 3) and thus could contribute to subthreshold depolarizations and the initiation of action potentials.
Discussion
Voltage-gated sodium channels mediate an increase in Na ϩ permeability during depolarization of membrane potential that underlies action potential electrogenesis. Although dysregulated sodium channel expression contributes to the pathophysiology of neuropathic pain (Matzner and Devor, 1994; Waxman et al., 2000) , mutations of voltage-gated sodium channel ␣-subunits, which underlie a number of human and animal disorders (for review, see Goldin, 2001; Keating and Sanguinetti, 2001; Meisler et al., 2001; Cannon, 2002) , were not associated with painful neuropathies until Yang et al. (2004) identified two mutations in SCN9A, the gene encoding Na v 1.7, in patients with primary erythermalgia. In this study, we have characterized the functional consequences of these two hNa v 1.7 mutations, I848T and L858H.
The I848T and L858H mutations are located in the S4 -S5 linker region of domain II (DIIS4 -S5) of the channel. Biophysical analysis of the mutant channels revealed several differences compared with wild-type hNa v 1.7. Both mutations significantly shifted the voltage dependence of activation in the hyperpolarizing direction. Deactivation of hNa v 1.7 was also slowed by both mutations, although the effect was much larger with the L858H mutation. Both mutations also significantly increased the size of ramp currents produced by hNa v 1.7 channels in response to slow depolarizations between Ϫ70 and Ϫ40 mV, a range that probably encompasses resting potential of sensory neurons (Harper and Lawson, 1985; Caffrey et al., 1992) . These changes in the functional properties of hNa v 1.7 are likely to contribute to increased excitability of spinal sensory neurons that express Na v 1.7 and may underlie the abnormal pain sensations in patients with inherited erythermalgia.
The I848T and L858H mutations shifted the voltage dependence of activation of hNa v 1.7 by almost 15 mV in a hyperpolarizing direction. A shift of this magnitude is expected to decrease the threshold for action potential generation in sensory neurons and increase neuronal excitability. Both mutations also significantly slowed the rate of deactivation of hNa v 1.7. Impaired deactivation of skeletal muscle sodium channels (Na v 1.4) has been hypothesized to contribute to abnormal muscle excitability (predominantly myotonia) in patients with paramyotonia congenita (Featherstone et al., 1998) . Many of the Na v 1.4 mutations that cause myotonia slow both the rate of fast inactivation and deactivation, and in computer simulations, this combination can induce a destabilization of repolarization after an action potential, leading to "myotonic runs" (Featherstone et al., 1998) . Unlike these Na v 1.4 mutations, the hNa v 1.7-I848T and -L858H did not slow the rate of fast inactivation, and therefore the hNa v 1.7 mutations might not destabilize repolarization.
The mutant hNa v 1.7 channels produced significantly larger currents in response to slow ramp depolarizations than wild-type channels. Increased overlap between the inactivation and activation curves, resulting from the large negative shift in the voltage dependence of activation (Fig. 1 B) and unchanged voltage dependence of steady-state inactivation (Fig. 2 B) , may underlie the larger ramp currents. Impaired deactivation, which indicates that the open-to-closed transition is altered, is also likely to contribute to the increased ramp current amplitudes. At negative potentials (less than Ϫ45 mV), the closing rate is much larger than the inactivation rate, and therefore channel openings are more likely to be terminated by deactivation than by inactivation in this voltage range (Vandenberg and Bezanilla, 1991) . Vandenberg and Bezanilla (1991) suggested that the deactivation rate of sodium channels limits the ability of sodium channels to open and reopen at negative potentials. Thus, slowing the deactivation rate would , and L858H (open triangles; n ϭ 17) hNa v 1.7 channels. Currents were elicited with test pulses to 0 mV after 500 msec inactivating prepulses. C, Comparison of steady-state slow inactivation for wild-type hNa v 1.7 (filled squares; n ϭ 9), I848T (open circles; n ϭ 8), and L858H (open triangles; n ϭ 9) hNa v 1.7 channels. Slow inactivation was induced with 30 sec prepulses, followed by 100 msec pulses to Ϫ120 mV to allow recovery from fast inactivation. A test pulse to 0 mV for 20 msec was used to determine the fraction of current available. Error bars represent SE.
be expected to increase the number of openings and open times at negative potentials, and this could contribute to increased ramp current amplitudes. The fact that the L858H mutant exhibited the slowest deactivation kinetics and the largest ramp currents is consistent with this hypothesis. Because the ramp currents are evoked between Ϫ70 and Ϫ40 mV, close to the resting potential of DRG neurons (Harper and Lawson, 1985; Caffrey et al., 1992) , the larger ramp currents in cells expressing mutant channels could amplify the response to small depolarizing inputs, increasing excitability. Na v 1.7 channels are expressed at high levels in small, mostly nociceptive, sensory neurons (Djouhri et al., 2003a) , suggesting that changes in activation, deactivation, and ramp current amplitude contribute to pain in erythermalgia patients with the I848T and L858H mutations.
The amino acid sequence of domain II S4 -S5 linker in hNa v 1.7 and hNa v 1.4 are identical (Yang et al., 2004) and are highly conserved when the sequence of all known sodium channels are aligned (data not shown). The conservation of this sequence suggests that the DIIS4 -S5 linker plays a similar role in different sodium channels. The I848T mutation in erythermalgia (Yang et al., 2004) corresponds to the I693T mutation in hNa v 1.4 of patients with episodic muscle weakness (Cannon, 2002) . The T704M mutation in hNa v 1.4 causes hyperkalemic periodic paralysis, another muscle disorder characterized by episodic weakness (Cannon, 2002) . The L858 in hNa v 1.7 corresponds to L703 in hNa v 1.4, which is immediately adjacent to the T704 residue. Thus, DIIS4 -S5 mutations in both hNa v 1.7 and hNa v 1.4 are associated with hereditary neurological and muscle disorders, which suggests that this linker contributes to the determination of biophysical properties of sodium channels including voltage dependence of activation and deactivation.
The functional consequences of the I693T and T704M mutations on hNa v 1.4 have been characterized after expression in HEK293 cells (Plassart-Schiess et al., 1998; Hayward et al., 1999; Bendahhou et al., 2002) and are similar to the effects of the I848T mutation on hNa v 1.7. All of these mutations shift the voltage dependence of activation in a hyperpolarizing direction. The Na v 1.4 mutations are thought to induce muscle weakness as a result of an enhanced persistent current (possibly attributable to window currents that result from the negative shift in the voltage dependence of activation) that depolarizes the muscle 5-10 mV, causing inactivation of the sodium currents and decreasing the ability of the muscle to fire action potentials (Lehmann-Horn et al., 1987; Cummins et al., 1993) . The hNa v 1.4-I693T and hNa v 1.4-T704M mutations also significantly impair slow inactivation, and this impairment is thought to contribute to muscle weakness associated with these mutations (Ruff, 1994) . However, whereas the I848T mutation impaired slow inactivation of hNa v 1.7, the L858H mutation of hNa v 1.7 enhanced slow inactivation. Because both mutations are associated with primary erythermalgia, this divergence might be interpreted as suggesting that slow inactivation is not important in its pathophysiology. Alternatively, there may be subtle differences in the symptoms of primary erythermalgia in patients with the I848T and L858H mutations attributable to the differential effect of the two mutations on slow inactivation.
Given that the I693T mutation in Na v 1.4 is associated with muscle weakness, how can the I848T mutation in Na v 1.7 be associated with increased pain sensations? One explanation may derive from the fact that whereas mature muscle cells express only Na v 1.4 channels, spinal sensory neurons express multiple sodium channel isoforms with distinct properties (Black et al., 1996) . The Na v 1.8 channel, which is expressed at high levels in many (but not all) spinal sensory neurons, has a very depolarized voltage dependence of inactivation compared with other channels such as Na v 1.4 and Na v 1.7 (Akopian et al., 1996) and plays a critical role in action potential firing in sensory neurons (Renganathan et al., 2001) . If the Na v 1.7-I848T mutation depolarizes the sensory neurons by 5-10 mV, as the Na v 1.4 mutations associated with muscle weakness are thought to do in muscle (Lehmann-Horn et al., 1987; Cannon, 2000) , the Na v 1.8 channels are likely to still be available for activation. Depolarizations of similar magnitudes might produce reduced action potential activity in muscle but could lead to enhanced excitability in neurons that also express Na v 1.8 because these cells would be closer to threshold for activation of Na v 1.8 currents. Thus, mutations of identical residues in Na v 1.7 and Na v 1.4 that have similar effects on channel properties could have differential effects on excitability and cause distinct neurological disorders because of the presence of multiple sodium channels (including Na v 1.8 which is not present in muscle) in spinal sensory neurons.
Non-nociceptive neurons are less likely to express Na v 1.8 channels than nociceptive neurons (Djouhri et al., 2003b) , and thus mutant Na v 1.7 channels could possibly differentially alter excitability in nociceptive and non-nociceptive neurons. Moreover, although Na v 1.7 currents exhibit similar properties in HEK293 cells and DRG neurons (Cummins et al., 1998; Herzog et al., 2003) , it is also possible that the mutant and wild-type Na v 1.7 channels are differentially modulated in DRG neurons, and this might contribute to the disease phenotype. For example, our studies in HEK293 cells were done with coexpression of the ␤1 and ␤2 subunits, but DRG neurons also express other ␤ subunits such as ␤3 (Shah et al., 2000) that could impact the current properties. Na v 1.4 and Na v 1.7 currents exhibit distinct properties (Cummins et al., 1998) and could be differentially modulated by ␤ subunits, and this could also contribute to the different disease phenotypes.
Our results highlight the fact that analogous mutations in sodium channels can result in dramatically different phenotypes and suggest that this difference may be attributable to the ensemble of other sodium channels (or channel subunits) that are expressed together with the mutant channel within DRG neurons. The changes in the electrophysiological properties of mutant hNa v 1.7 provide the first example of altered sodium channel function in a hereditary pain syndrome and suggest that targeting of sodium channels may provide a useful therapeutic strategy for this disorder.
